Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 1998
A RANTES-antibody fusion protein retains antigen specificity and chemokine functionP M Challita-Eid, C N Abboud, S L Morrison, et al.Bone Marrow Transplantation|January 14, 2009
Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATGM G Martin, G L Uy, E Procknow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.Blood Cells, Molecules & Diseases|August 3, 2001
Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genesA P Rapoport, M Simons-Evelyn, T Chen, et al.Bone Marrow Transplantation|April 1, 1995
Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 yearsA P Rapoport, J F DiPersio, B A Martin, et al.Bone Marrow Transplantation|July 29, 2014
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myelomaT-F Wang, M A Fiala, A F Cashen, et al.Seminars in Oncology|February 24, 2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary reportG L Phillips, C N Abboud, S H Bernstein, et al.Bone Marrow Transplantation|March 14, 2000
Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamideR E Duerst, J T Horan, J L Liesveld, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2011
Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literatureJ S Chawla, A Ghobadi, J Mosley, et al.Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.Pageof 8